Alex Zhavoronkov

Biotech Techbio

One of the loudest advocates for AI-first drug discovery and CEO of Insilico Medicine.

CITERANK · AUTHORITY ACROSS AI ENGINES

AI-cited voice

◆ FREE

820 followers

CiteRank

Estimated · single engine (Perplexity)As measured on 25 Jul 2026

ANSWER SHARE—

CITATION POTENTIAL—

CLAIM THIS PROFILEAre you Alex? Verify to manage your CiteRank.

INTELLECTUAL PROFILEDERIVED FROM PUBLISHED WORK

WHAT MAKES THIS VOICE DISTINCT

This voice is distinctive in its focus on the intersection of AI and biotech, particularly in the pharma industry. They regularly highlight the potential of AI-empowered treatments and innovations, such as Insilico Medicine's AI-driven tools. For example, the post on 'Transforming Parkinson’s Disease Treatment' showcases their emphasis on AI's role in medical breakthroughs.

biotech-techbioTone: data-drivenPOV strength 6/10

short opinion takes

announcement-style updates on company progress

HOW THIS VOICE SHOWS UP

+names concrete tools and companies

+references specific medical conditions and treatments

+mentions industry events and conferences

TOPICS THEY OWN

◆Biotech & techbio

◆Longevity & healthspan

SHARE OF VOICENAMED IN 1 TOPIC · AVG 4.0% · BEST #11

Of all the names AI gives for a topic, the share that goes to this voice. Measured on prompts that don't mention anyone by name.

TOPICSHAREPOSITIONENGINES

Biotech & techbio

named as "Alex Zhavoronkov"

4.0%#11 of 26NaN

POSITIONS ON NARRATIVES

Not yet appearing in any tracked narrative. As this voice is cited across AI answers, their positions will surface here.

Is this you? Request a correction, dispute the score, or ask to be removed. No account needed.